Y's Square:病院感染、院内感染対策学術情報 > 感染対策学術情報 > 消毒薬テキスト(Y’s Text) > V 各種消毒薬の特性 > V 章 参考文献
Y’s Text
V 各種消毒薬の特性

V 章 参考文献

1)
小林寬伊,大久保憲,尾家重治:消毒薬.小林寬伊編集.[新版 増補版]消毒と滅菌のガイドライン.へるす出版,東京,2015;121-144.
2)
石塚紀元,小林寬伊,尾家重治:消毒薬.小林寬伊編集.感染制御学.へるす出版,東京,1996;125-156.
3)
Favero MS, Bond WW:Chemical disinfection of medical and surgical materials. In:Block SS, ed. Disinfection, Sterilization, and Preservation, 5th ed. Philadelphia:Lippin-cott Williams & Wilkins, 2001;881-917.
4)
Widmer AF, Frei R:Decontamination, disinfection, and sterilization. In:Murray PR, et al ed. Manual of clinical microbiology, 7th ed. Washington DC:ASM Press 1999;138-164
5)
Rutala WA:APIC Guideline for selection and use of disinfectants, 1996. Am J Infect Control 1996;24:313-342.
6)
Merianos JJ:Surface-active agents. In:Block SS, ed. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia:Lippin- cott Williams & Wilkins, 2001;283-320.
7)
吉田製薬株式会社.吉田製薬添付文書集 2016.2016.
8)
日本医薬情報センター編.医療薬日本医薬品集.じほう,東京,2004.
9)
Frank MJ, Schaffner W:Contaminated aqueous Benzalkonium Chloride. JAMA 1976;236:2418-2419.
10)
和田英己,佐藤隆一,滝沢真紀,他:「インスベン液0.1」の防錆効果と殺菌効果.医学と薬学 2003;50:323-328.
11)
尾家重治,藤田陽子,他:気管内吸引チューブ浸漬用消毒薬(ザルコニンA液0.1)の使用後の微生物汚染調査.医学と薬学 1999;42:989-991.
12)
HICPAC, et al.:Guideline for Hand Hygiene in Health-Care Settings. MMWR 2002;51 (RR-16):1-45.
13)
大久保憲訳,小林寬伊監訳:医療現場における手指衛生のためのCDCガイドライン.メディカ出版,大阪,2003.
14)
Larson EL:APIC Guideline for handwashing and hand antisepsis in health care settings, 1995. Am J Infect Control 1995;23:251-269.
15)
Denton GW:Chlorhexidine. In:Block SS, ed. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia:Lippin- cott Williams & Wilkins, 2001;321-336.
16)
Kobayashi H, Tsuzuki M, Hosobuchi K:Bactericidal effects of antiseptics and disinfectants against methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1989;10:562-564.
17)
国定孝夫,山田恵子,織田志保美:消毒剤のIn Vitro有効性評価法の検討.環境感染1999;14:127-131.
18)
Brumfitt W, Dixson S, Hamilton-Miller JMT:Resistance to antiseptics in methicillin and gentamicin resistant Staphylococcus aureus. Lancet 1985;I:1442-1443.
19)
al-Masaudi SB, Day MJ, Russell AD:Sensitivity of methicillin-resistant Staphylococcus aureus strains to some antibiotics, antiseptics and disinfectants. J Appl Bacteriol 1988;65:329-337.
20)
吉村正一郎,安田忠司,勝野陽子,他:MSSAとMRSAに対する消毒剤の殺菌効果の比較.医薬ジャーナル 1989;25:317-322.
21)
甲斐幹夫,青野昭男,松本秀勝,他:院内感染起因菌に対する繁用消毒剤の効力比較.医薬ジャーナル 1992;28:283-292.
22)
Paulsen IT, Brown MB, Skurray RA:Proton-Dependent Multidrug Efflux Systems. Microbiol Rev 1996;60:575-608.
23)
Merianos JJ:Surface-active Agents:Amphoteric Compound. In:Block SS, ed. Disinfection, Sterilization, and Preservation. 4th ed. Philadelphia:Lea & Febiger, 1991;263-273.
24)
青野昭男,桑原龍児,房野研,他:各種消毒薬の抗酸菌に対する殺菌効果と血清添加がそれに及ぼす影響.基礎と臨床 1997;31:2655-2666.
25)
Ali Y, Dolan MJ, Fendler EJ, et al.:Alcohols. In:Block SS, ed. Disinfection, Sterilization, and Preservation.5th ed. Philadelphia:Lippin- cott Williams & Wilkins, 2001;229-253.
26)
白石正,丘龍祥,仲川義人:エタノール,イソプロパノール,メタノール変性アルコール製剤に関する殺菌効力の検討.環境感染 1998;13:108-112.
27)
野田伸司,渡辺実,山田不二造,他:アルコール類のウイルス不活化作用に関する研究-ウイルスに対する各種アルコールの不活化効果について.感染症学雑誌 1981;55:355-366.
28)
佐藤隆一,和田英己,滝沢真紀、他:各種アルコール系消毒薬の評価.医学と薬学 2003;49:713-724.
29)
Kobayashi H, Tsuzuki M, Koshimizu K, et al.:Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol 1984;20:214-216.
30)
Bond WW, Favero MS, Petersen JN, et al.:Inactivation of hepatitis B virus by intermediate to high level disinfectant chemicals. J Clin Microbiol 1983;18:535-538.
31)
吉成昌郎,中井益代,清金公裕:市販消毒剤の有用性~ネオ消アル「ヨシダ」と日局消毒エタノールの比較~.医薬ジャーナル 1994;30:883-886.
32)
梶浦工,青木孝夫,福武勝彦:低級アルコール製剤の消毒作用に関する検討.基礎と臨床 1997;31:3221-3227.
33)
加藤真吾,平石佳之,富永恵子,他:プラーク法を用いた各種消毒剤によるHIV-1不活化の検討.基礎と臨床 1996;30:495-500.
34)
Gottardi W:Iodine and iodine compounds. In:Block SS, ed. Disinfection, Sterilization, and Preservation, 5th ed. Philadelphia:Lippin- cott Williams & Wilkins, 2001;159-183.
35)
Payne DN, Babb JR, Bradley CR:An evaluation of the suitability of the European suspension test to reflect in vitro activity of antiseptics against clinically significant organisms. Lett Appl Microbiol 1999;28:7-12.
36)
CDC:Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008.
37)
Barkelman RL, Lewin S, Allen R, et al.:Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Int Med 1981;95:32-36.
38)
Little JR, Murray PR, Traynor PS, et al.:A randomized trial of povidone-iodine compared with Iodine tincture for venipuncture site disinfection:Effects on rates of blood culture contamination. Am J Med 1999;107:119-125.
39)
Rannem T, Ladefogedo K, Hegnhoj F, et al.:Catheter-related sepsis in long-term parenteral nutrition with broviac catheters:An evaluation of different disinfectants. Clinical Nutrition 1990;9:131-136.
40)
Dychdala GR:Chlorine and Chlorine Compounds. In:Block SS, ed. Disinfection, Sterilization, and Preservation,5th ed. Philadelphia:Lippin- cott Williams & Wilkins, 2001;135-157.
41)
Oie S, Obayashi A, Yamasaki H, et al.:Disinfection methods for spores of Bacillus atrophaeus, B. anthracis, Clostridium tetani, C. botulinum and C. difficile. Biol Pharm Bull 2011;34:1325-1329.
42)
小林義正,小林寬伊,梶浦工,他:次亜塩素酸ナトリウム含浸環境清拭クロスの残留塩素濃度に関する検討.医療関連感染 2015;8:17-26.
43)
日本医薬情報センター編集.一般用医薬品集2016.丸善,東京,2015.
44)
Bloomfield SF, Uso EE:The antibacterial properties of sodium hypochlorite and sodium dichloroisocyanurate as hospital disinfectants. J Hosp Inf 1985;6:20-30.
45)
Coates D:Comparison of sodium hypochlorite and sodium dichloroisocyanurate disinfectants:neutralization by serum. J Hosp Inf 1988;11:60-67.
46)
山岡学,梶浦工,滝沢真紀,他:発泡顆粒「ジクロシア」の基礎的検討.医学と薬学2003;50:183-192.
47)
Bloomfield SF, Miles GA:The antibacterial properties of sodium dichloroisocyanurate and sodium hypochlorite formulations. J Appl Bacteriol 1979;46:65-73.
48)
白石正,仲川義人:ジクロロイソシアヌル酸Na顆粒の有機物存在下における殺菌効果の検討.臨床と微生物 1996;23:93-95.
49)
大久保憲:電解酸性水の殺菌機序とその有用性.オペナーシング 1995;10:129-134.
50)
大久保憲:注目される感染防止対策 1.電解酸性水の評価と新しい消毒法.日本手術部医学会誌 1996;17:364-367.
51)
岩沢篤朗,中村良子:強酸性電解水の殺菌効果と実用上の留意点.Infection Control 1999;8:128-133.
52)
堀田国元,他:講座 強酸性電解水.防菌防黴 1999;27:447-492.
53)
岡上晃,小澤智子,小倉憂也,他:複合型塩素系除菌・洗浄剤の各種環境表面素材に対する影響に関する検討.環境感染誌 2015.30;325-330.
54)
Environmental Protection Agency:Selected EPA-registered Disinfectants.2015. at http://www.epa.gov/oppad001/chemregindex.htm
55)
Goddard PA, McCue KA:Phenolic Compounds. In:Block SS, ed. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia:Lippin- cott Williams & Wilkins 2001;255-281.
56)
Narang HK, Codd AA:Action of commonly used disinfectants against enteroviruses. J Hosp Infect 1983;4:209-212.
57)
Klein M, Deforest A:The inactivation of viruses by germicides. Proc Chem Spec Mfr Assoc 1963;May:116-118.
58)
Scott EM, Gorman SP:Glutaraldehyde. In:Block SS, ed. Disinfection, Sterilization, and Preservation, 5th ed. Philadelphia:Lippin- cott Williams & Wilkins 2001;361-381.
59)
FDA.FDA-Cleared Sterilants and High Level Disinfectants with General Claims for Processing Reusable Medical and Dental Devices, March 2015. 2015. at http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ReprocessingofReusableMedicalDevices/ucm437347.htm
60)
Walsh SE, Mailard JY, Russell AD:Ortho-phthalaldehyde: a possible alternative to glutaraldehyde for high level disinfection. J Applied Microbiology 1999;84:1039-1046.
61)
Manzoor SE, Lambert PA, Griffiths PA, et al.:Reduced glutaralaldehyde susceptibility in Mycobacterium chelonae associated with altered cell wall polysaccharides. J Antimicrob Chemother 1999;43:759-765.
62)
厚生労働省労働基準局長基発第0224008号.医療機関におけるグルタルアルデヒドによる労働者の健康障害防止について(平成17年2月24日).2005.
63)
Alfa MJ, Sitter DL:In-hospital evaluation of orthophtalaldehyde as a high level disinfectant for flexible endoscopes. J Hosp Infect 1994;26:15-26.
64)
Alvarado CJ, Reichelderfer M:APIC guideline for infection prevention and control in flexible endoscopy. Am J Infect Control 2000;28:138-155.
65)
Sokol WN:Nine episodes of anaphylaxis following cystoscopy caused by Cidex OPA (ortho-phthalaldehyde)high-level disinfectant in 4 patients after cytoscopy. J Allergy Clin Immunol 2004;114:392-397.
66)
Venticinque SG, Kashyap VS, O’Connell RJ:Chemical burn injury secondary to intraoperative transesophageal echocardiography. Anesth Analg 2003;97:1260-1261.
67)
Block SS:Peroxygen Compounds. In:Block SS, ed. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia:Lippin- cott Williams & Wilkins, 2001;185-204.
68)
Malchesky PS:Medical Applications of Peracetic Acid. In:Block SS, ed. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia:Lippin- cott Williams & Wilkins, 2001;979-996.
69)
Working Party of the British Society of Gastroenterology Endoscopy Committee:Cleaning and disinfection of equipment for gastrointestinal endoscopy. Gut 1998;42: 585-593.
70)
Ogata N:Denaturation of protein by chlorine dioxide: oxidative modification of tryptophan and tyrosine residues.Biochemistry 2007 A;46:4898-911.
71)
Javed F, Sood S, Banfield G:Decontamination methods for flexible nasal endoscopes. Br J Nurs 2014;23:850-852.
72)
Gilling PJ, Reuther RM, Addidle M, et al.:A randomized single-blind comparison of the effectiveness of Tristel Fuse(chlorine dioxide)as an office-based fluid soak, with Cidex OPA(ortho-phthaldehyde)using an automated endoscopic reprecessor(AER)as high-level disinfection for flexible cystoscopies. BJU Int 2013;112:69-73.
73)
日本二酸化塩素工業会ホームページ.at http://chlorinedioxide.or.jp/
74)
宮野直之,尾家重治,神谷晃:アクリノールの抗菌活性.病院薬学 1992;18:472-476.
75)
Rossmoore HW:Nitrogen Compounds. In:Block SS, ed. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia:Lippin- cott Williams & Wilkins, 2001;383-413.
76)
厚生労働省令155号.特定化学物質障害予防規則等の一部を改正する省令(平成19年12月28日).2007.

関連サイト